
|Articles|March 1, 2003
GA Subset Served
Sandusky, Ohio - Tacrolimus 0.1 percent ointment can treat a subset of patients with granuloma annulare (GA), according to a study conducted at Northern Ohio Dermatology Research in Sandusky, Ohio. The phase IV, open-label, single-center, clinical trial was conducted by Mandi R. Motter, R.N., clinical research coordinator, Thomas E. Fleming, M.D., principal investigator, and colleagues.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
3
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
4
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
5














